In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks: pooled analysis of two Scandinavian trials
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | European Journal of Gastroenterology and Hepatology |
| Volume | 22 |
| Issue number | 5 |
| Pages (from-to) | 552-556 |
| Number of pages | 4 |
| ISSN | 0954-691X |
| Publication status | Published - 1 May 2010 |
- Former Faculty of Pharmaceutical Sciences
Research areas
ID: 33788426